[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fuzuHbwuYubVrvRvYX-0KzonpME_pb4Jpp_t1S3E0t1I":3,"$f02GC61UXqQnDZlTVwCRCmNL2e7nK4hffDirqYV4Mjmw":8,"$fCgEofashUM1Pr1W-7VF2eqQrzDpwoC51KKsoOcIqW44":19,"questionHotTemplate-y13qqn":129,"$fJhR-8YjGysbWGdGl_jPyOd6aZZNBRtSH522Z-giMRDo":130},{"resultCode":4,"resultMsg":5,"data":6},"200","成功",{"questionId":7},2986,{"resultCode":4,"resultMsg":5,"data":9},{"title":10,"questionId":7,"quoteQuantity":11,"subjectQuantity":12,"templateUrl":13,"visits":14,"collectQuantity":15,"questionType":11,"isQuestionCopy":11,"userName":16,"modifyTime":17,"questionCode":13,"questionKeys":18,"questionDesc":13},"DME治疗情况专家调查问卷",1,11,null,7,0,"13001239017",1658447692000,"问卷制作平台,问卷结果导出,问卷二维码",{"resultCode":4,"resultMsg":5,"data":20},{"curPage":21,"pageSize":12,"total":22,"totalPage":23,"data":24},8,365,34,[25,36,46,55,65,75,85,94,103,111,120],{"title":26,"questionId":27,"quoteQuantity":28,"subjectQuantity":29,"templateUrl":30,"visits":31,"collectQuantity":13,"questionType":32,"isQuestionCopy":11,"userName":13,"modifyTime":33,"questionCode":34,"questionKeys":35,"questionDesc":13},"金融知识普及月——金融知识小问答",79265,358,26,"https:\u002F\u002Fimage.longyixiu.com\u002Fe1716854e55e4e7bade64482e83e3a1b",659,2,1695010631000,"1r7rz0a","驾照模拟考试,在线作业考试,在线培训考核",{"title":37,"questionId":38,"quoteQuantity":39,"subjectQuantity":40,"templateUrl":41,"visits":42,"collectQuantity":13,"questionType":32,"isQuestionCopy":11,"userName":13,"modifyTime":43,"questionCode":44,"questionKeys":45,"questionDesc":13},"“建党百年 恪尽职守 热诚服务”",2219,356,13,"https:\u002F\u002Fimage.longyixiu.com\u002Fd844ea7d1ac248878200ec5a80cb8db5",159,1658313129000,"69j7th6u","考试管理平台,在线测评工具,线上考试工具",{"title":47,"questionId":48,"quoteQuantity":49,"subjectQuantity":12,"templateUrl":50,"visits":51,"collectQuantity":13,"questionType":11,"isQuestionCopy":11,"userName":13,"modifyTime":52,"questionCode":53,"questionKeys":54,"questionDesc":13},"烘焙食品市场调查",327,353,"https:\u002F\u002Fimage.longyixiu.com\u002F0e2892449efd49e18b5e2f018d0517ca",357,1663642386000,"eckvkxf","问卷自定义样式,问卷制作工具,问卷逻辑跳转",{"title":56,"questionId":57,"quoteQuantity":58,"subjectQuantity":59,"templateUrl":60,"visits":61,"collectQuantity":13,"questionType":59,"isQuestionCopy":11,"userName":13,"modifyTime":62,"questionCode":63,"questionKeys":64,"questionDesc":13},"课外学习进度情况反馈",3299,351,5,"https:\u002F\u002Fimage.longyixiu.com\u002F91979f23e7234598a0655eaf9fc9c1ef",1889,1729046761000,"vwat9li","群接龙,在线接龙,社群接龙",{"title":66,"questionId":67,"quoteQuantity":68,"subjectQuantity":69,"templateUrl":70,"visits":71,"collectQuantity":13,"questionType":32,"isQuestionCopy":11,"userName":13,"modifyTime":72,"questionCode":73,"questionKeys":74,"questionDesc":13},"古诗词知识竞赛题-龙艺秀",66372,347,54,"https:\u002F\u002Fimage.longyixiu.com\u002F026e7dc3ec5d428aae8166754d06fa61",7292,1690339004000,"s8jpa","内部培训考试,员工能力测评,教育测评平台",{"title":76,"questionId":77,"quoteQuantity":78,"subjectQuantity":79,"templateUrl":80,"visits":81,"collectQuantity":13,"questionType":11,"isQuestionCopy":11,"userName":13,"modifyTime":82,"questionCode":83,"questionKeys":84,"questionDesc":13},"关于国际护士节问卷调研",42840,346,20,"https:\u002F\u002Fimage.longyixiu.com\u002F558bd6f55dd9453493e987d71f5512aa",1004,1689931549000,"8eu68","问卷实时回收,微信问卷平台,小程序答题",{"title":86,"questionId":87,"quoteQuantity":88,"subjectQuantity":89,"templateUrl":90,"visits":91,"collectQuantity":13,"questionType":59,"isQuestionCopy":11,"userName":13,"modifyTime":62,"questionCode":92,"questionKeys":93,"questionDesc":13},"每日网课签到打卡",3215,334,4,"https:\u002F\u002Fimage.longyixiu.com\u002F66c3674021c9430ca3dcc839ce61b883",1283,"m80d188","学校接龙,接龙状态查询,多人接龙",{"title":95,"questionId":96,"quoteQuantity":88,"subjectQuantity":97,"templateUrl":98,"visits":99,"collectQuantity":13,"questionType":32,"isQuestionCopy":11,"userName":13,"modifyTime":100,"questionCode":101,"questionKeys":102,"questionDesc":13},"6•9国际档案日档案知识竞赛",55189,69,"https:\u002F\u002Fimage.longyixiu.com\u002F6572580e8c2b42c5aa656e335fa9de32",338,1685948601000,"0lpt8uxe","考试成绩统计,在线考试平台,员工培训考试",{"title":104,"questionId":105,"quoteQuantity":88,"subjectQuantity":106,"templateUrl":107,"visits":49,"collectQuantity":13,"questionType":32,"isQuestionCopy":11,"userName":13,"modifyTime":108,"questionCode":109,"questionKeys":110,"questionDesc":13},"【培训考试】关联图谱培训考试",189,9,"https:\u002F\u002Fimage.longyixiu.com\u002F40ae6508cb234554923c378ceeacd4f2",1677134695000,"sro20","在线培训考核,随机组卷,在线课堂测验",{"title":112,"questionId":113,"quoteQuantity":114,"subjectQuantity":23,"templateUrl":115,"visits":116,"collectQuantity":13,"questionType":32,"isQuestionCopy":11,"userName":13,"modifyTime":117,"questionCode":118,"questionKeys":119,"questionDesc":13},"基孔肯雅热防控知识测试",446647,330,"https:\u002F\u002Fimage.longyixiu.com\u002F5fed93ee413743e397a941295eb0cf10.png",106,1760948233000,"12k7bf","在线考务系统,员工考核系统,企业入职考试",{"title":121,"questionId":122,"quoteQuantity":123,"subjectQuantity":106,"templateUrl":124,"visits":125,"collectQuantity":13,"questionType":11,"isQuestionCopy":11,"userName":13,"modifyTime":126,"questionCode":127,"questionKeys":128,"questionDesc":13},"xx小区满意度调查问卷",153266,328,"https:\u002F\u002Fimage.longyixiu.com\u002Ffe107503db0f490796dfb16b6ea551db.png",869,1711678543000,"w6dq1ai","问卷软件,问卷制作工具,问卷API接口",["Reactive",20],{"resultCode":4,"resultMsg":5,"data":131},[132,154,167,184,200,217,235,249,269,286],{"subjectId":133,"subjectTitle":134,"subjectSubtitle":13,"subjectType":11,"titleIndex":11,"indexName":135,"subjectTypeName":136,"optionList":137},23347,"\u003Cp>您一个月接诊的DME患者大约有多少？\u003C\u002Fp>","1","单选题",[138,141,145,150],{"optionId":139,"optionTitle":140,"optionSubtitle":13,"titleIndex":11,"indexName":135},64508,"\u003Cp>≤5\u003C\u002Fp>",{"optionId":142,"optionTitle":143,"optionSubtitle":13,"titleIndex":32,"indexName":144},64509,"\u003Cp>>5,≤15\u003C\u002Fp>","2",{"optionId":146,"optionTitle":147,"optionSubtitle":13,"titleIndex":148,"indexName":149},64510,"\u003Cp>>15,≤30\u003C\u002Fp>",3,"3",{"optionId":151,"optionTitle":152,"optionSubtitle":13,"titleIndex":89,"indexName":153},64511,"\u003Cp>>30\u003C\u002Fp>","4",{"subjectId":155,"subjectTitle":156,"subjectSubtitle":13,"subjectType":11,"titleIndex":32,"indexName":144,"subjectTypeName":136,"optionList":157},23348,"\u003Cp>您接诊的未经治的DME患者视力程度在哪个范围的更多？ETDRS\u003C\u002Fp>",[158,161,164],{"optionId":159,"optionTitle":160,"optionSubtitle":13,"titleIndex":11,"indexName":135},64512,"\u003Cp>20\u002F30或更好\u003C\u002Fp>",{"optionId":162,"optionTitle":163,"optionSubtitle":13,"titleIndex":32,"indexName":144},64513,"\u003Cp>20\u002F30和20\u002F50之间\u003C\u002Fp>",{"optionId":165,"optionTitle":166,"optionSubtitle":13,"titleIndex":148,"indexName":149},64514,"\u003Cp>20\u002F50或更差\u003C\u002Fp>",{"subjectId":168,"subjectTitle":169,"subjectSubtitle":13,"subjectType":32,"titleIndex":148,"indexName":149,"subjectTypeName":170,"optionList":171},23351,"\u003Cp>您的DME患者从发病机制来说更符合哪种情形？ (可多选)\u003C\u002Fp>","多选题",[172,175,178,181],{"optionId":173,"optionTitle":174,"optionSubtitle":13,"titleIndex":11,"indexName":135},64521,"\u003Cp>主要VEGF因素，炎症因素较少\u003C\u002Fp>",{"optionId":176,"optionTitle":177,"optionSubtitle":13,"titleIndex":32,"indexName":144},64522,"\u003Cp>主要炎症因素，VEGF因素其次\u003C\u002Fp>",{"optionId":179,"optionTitle":180,"optionSubtitle":13,"titleIndex":148,"indexName":149},64523,"\u003Cp>难说VEGF和炎症因素哪个更多\u003C\u002Fp>",{"optionId":182,"optionTitle":183,"optionSubtitle":13,"titleIndex":89,"indexName":153},64524,"\u003Cp>其他因素\u003C\u002Fp>",{"subjectId":185,"subjectTitle":186,"subjectSubtitle":13,"subjectType":11,"titleIndex":89,"indexName":153,"subjectTypeName":136,"optionList":187},23352,"\u003Cp>在控制好DM的基础上，以下描述哪个更接近您在DME上的治疗选择？\u003C\u002Fp>",[188,191,194,197],{"optionId":189,"optionTitle":190,"optionSubtitle":13,"titleIndex":11,"indexName":135},64525,"\u003Cp>首选抗VEGF并坚持一种药物长期治疗观察\u003C\u002Fp>",{"optionId":192,"optionTitle":193,"optionSubtitle":13,"titleIndex":32,"indexName":144},64526,"\u003Cp>首选抗VEGF并根据早期应答看是否要调整到其他药物或联合其他治疗方法\u003C\u002Fp>",{"optionId":195,"optionTitle":196,"optionSubtitle":13,"titleIndex":148,"indexName":149},64527,"\u003Cp>首选激素类药物治疗并根据早期应答看是否调整到其他药物或联合其他方法\u003C\u002Fp>",{"optionId":198,"optionTitle":199,"optionSubtitle":13,"titleIndex":89,"indexName":153},64528,"\u003Cp>没有首选偏好，根据患者情况采取个体化方案\u003C\u002Fp>",{"subjectId":201,"subjectTitle":202,"subjectSubtitle":13,"subjectType":11,"titleIndex":59,"indexName":203,"subjectTypeName":136,"optionList":204},23482,"\u003Cp>您的DME患者如果抗VEGF治疗应答不理想，您通常在几针后会调整方案？\u003C\u002Fp>","5",[205,208,211,214],{"optionId":206,"optionTitle":207,"optionSubtitle":13,"titleIndex":11,"indexName":135},64960,"\u003Cp>1针\u003C\u002Fp>",{"optionId":209,"optionTitle":210,"optionSubtitle":13,"titleIndex":32,"indexName":144},64961,"\u003Cp>2针\u003C\u002Fp>",{"optionId":212,"optionTitle":213,"optionSubtitle":13,"titleIndex":148,"indexName":149},64962,"\u003Cp>3针\u003C\u002Fp>",{"optionId":215,"optionTitle":216,"optionSubtitle":13,"titleIndex":89,"indexName":153},64963,"\u003Cp>4针以上\u003C\u002Fp>",{"subjectId":218,"subjectTitle":219,"subjectSubtitle":13,"subjectType":11,"titleIndex":220,"indexName":221,"subjectTypeName":136,"optionList":222},23353,"\u003Cp>您的患者如果在接受抗VEGF治疗，实际一年内治疗次数在哪个范围的人更多？\u003C\u002Fp>",6,"6",[223,226,229,232],{"optionId":224,"optionTitle":225,"optionSubtitle":13,"titleIndex":11,"indexName":135},64529,"\u003Cp>≤2次\u003C\u002Fp>",{"optionId":227,"optionTitle":228,"optionSubtitle":13,"titleIndex":32,"indexName":144},64530,"\u003Cp>>2次，≤4次\u003C\u002Fp>",{"optionId":230,"optionTitle":231,"optionSubtitle":13,"titleIndex":148,"indexName":149},64531,"\u003Cp>>4次，≤6次\u003C\u002Fp>",{"optionId":233,"optionTitle":234,"optionSubtitle":13,"titleIndex":89,"indexName":153},64533,"\u003Cp>>6次\u003C\u002Fp>",{"subjectId":236,"subjectTitle":237,"subjectSubtitle":13,"subjectType":11,"titleIndex":14,"indexName":238,"subjectTypeName":136,"optionList":239},23355,"\u003Cp>OphthalmologyRetina今年有一篇超过130,000只眼的Meta分析显示一年内抗VEGF注射不足7次的，BCVA改善平均2.4到3.8。您的经验是？\u003C\u002Fp>","7",[240,243,246],{"optionId":241,"optionTitle":242,"optionSubtitle":13,"titleIndex":11,"indexName":135},64534,"\u003Cp>差不多\u003C\u002Fp>",{"optionId":244,"optionTitle":245,"optionSubtitle":13,"titleIndex":32,"indexName":144},64535,"\u003Cp>比这个稍好，平均能改善4到6个字母\u003C\u002Fp>",{"optionId":247,"optionTitle":248,"optionSubtitle":13,"titleIndex":148,"indexName":149},64536,"\u003Cp>比这个好的多，平均能改善7个字母以上\u003C\u002Fp>",{"subjectId":250,"subjectTitle":251,"subjectSubtitle":13,"subjectType":32,"titleIndex":21,"indexName":252,"subjectTypeName":170,"optionList":253},23356,"\u003Cp>对于一年内注射次数不足六次的患者，您认为下面哪种原因更普遍？（可多选）\u003C\u002Fp>","8",[254,257,260,263,266],{"optionId":255,"optionTitle":256,"optionSubtitle":13,"titleIndex":11,"indexName":135},64537,"\u003Cp>经济原因\u003C\u002Fp>",{"optionId":258,"optionTitle":259,"optionSubtitle":13,"titleIndex":32,"indexName":144},64538,"\u003Cp>不方便按时间来医院\u003C\u002Fp>",{"optionId":261,"optionTitle":262,"optionSubtitle":13,"titleIndex":148,"indexName":149},64541,"\u003Cp>对疗效不满意，不愿继续治疗\u003C\u002Fp>",{"optionId":264,"optionTitle":265,"optionSubtitle":13,"titleIndex":89,"indexName":153},64542,"\u003Cp>自认为达到效果，不再来治疗\u003C\u002Fp>",{"optionId":267,"optionTitle":268,"optionSubtitle":13,"titleIndex":59,"indexName":203},64543,"\u003Cp>其他原因\u003C\u002Fp>",{"subjectId":270,"subjectTitle":271,"subjectSubtitle":13,"subjectType":32,"titleIndex":106,"indexName":272,"subjectTypeName":170,"optionList":273},23362,"\u003Cp>地塞米松纳米颗粒滴眼液二期结果BCVA≤ 60的患者12周BCVA均值增加5.2，安全耐受与其他激素治疗类似。其应用前景您支持哪种？ (可多选)\u003C\u002Fp>","9",[274,277,280,283],{"optionId":275,"optionTitle":276,"optionSubtitle":13,"titleIndex":11,"indexName":135},64544,"\u003Cp>可以早期运用到轻中度患者\u003C\u002Fp>",{"optionId":278,"optionTitle":279,"optionSubtitle":13,"titleIndex":32,"indexName":144},64554,"\u003Cp>可以在注射抗VEGF药物后序贯，或在注射抗VEGF药物间隔期使用\u003C\u002Fp>",{"optionId":281,"optionTitle":282,"optionSubtitle":13,"titleIndex":148,"indexName":149},64555,"\u003Cp>和地塞米松植入剂一样，运用到不适合抗VEGF治疗的患者\u003C\u002Fp>",{"optionId":284,"optionTitle":285,"optionSubtitle":13,"titleIndex":89,"indexName":153},64964,"\u003Cp>在球内注射缓释激素之前，可先用这一款滴眼液治疗，评估对激素治疗的应答\u003C\u002Fp>",{"subjectId":287,"subjectTitle":288,"subjectSubtitle":13,"subjectType":32,"titleIndex":289,"indexName":290,"subjectTypeName":170,"optionList":291},23365,"\u003Cp>对上面提到的地塞米松纳米颗粒滴眼液，您还想了解哪些方面？(可多选)\u003C\u002Fp>",10,"10",[292,295,298,301],{"optionId":293,"optionTitle":294,"optionSubtitle":13,"titleIndex":11,"indexName":135},64556,"\u003Cp>二期临床的详细数据\u003C\u002Fp>",{"optionId":296,"optionTitle":297,"optionSubtitle":13,"titleIndex":32,"indexName":144},64557,"\u003Cp>滴眼液递送到眼底的技术资料\u003C\u002Fp>",{"optionId":299,"optionTitle":300,"optionSubtitle":13,"titleIndex":148,"indexName":149},64558,"\u003Cp>在中国的临床和上市计划\u003C\u002Fp>",{"optionId":302,"optionTitle":303,"optionSubtitle":13,"titleIndex":89,"indexName":153},64559,"\u003Cp>和其他药物比较或联合使用的资料\u003C\u002Fp>"]